EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Ex Vivo Electroretinographic Apparatus for the mL-Scale Testing of Drugs to One Day and Beyond

Lorenzo Cangiano iD, Sabrina Asteriti

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Lorenzo Cangiano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research, University of Pisa, 56123 Pisa, Italy. Hauptthemen laut MEDLINE: Electroretinography, Retina. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Velux Stiftung, PNRR Tuscany Health Ecosystem milestones 4.3.2 and 8.9.1.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When screening new drugs to treat retinal diseases, ex vivo electroretinography (ERG) potentially combines the experimental throughput of its traditional in vivo counterpart, with greater mechanistic insight and reproducible delivery. To date, this technique was used in experiments with open loop superfusion and lasting up to a few hours. Here, we present a compact apparatus that provides continuous and simultaneous recordings of the scotopic a-waves from four mouse retinas for much longer durations. Crucially, each retina can be incubated at 37 °C in only 2 mL of static medium, enabling the testing of very expensive drugs or nano devices. Light sensitivity and response kinetics of these preparations remain in the physiological range throughout incubation, displaying only very slow drifts. As an example application, we showed that barium, a potassium channel blocker used to abolish the glial component of the ERG, displayed no overt side effects on photoreceptors over several hours. In another example, we fully regenerated a partially bleached retina using a minimal quantity of 9-cis-retinal. Finally, we demonstrated that including antibiotic in the incubation medium extends physiological light responses to over one day. This system represents a necessary stepping stone towards the goal of combining ERG recordings with organotypically cultured retinas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectroretinographyRetinaMiceAnimalsPharmaceutical PreparationsPhotoreceptor CellsNeuroglia

Stichwörter der Autor:innen

ERGdrugex vivoincubationmousepharmacologyretinatherapy

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Translational Research, University of Pisa, 56123 Pisa, Italy.
  • Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

ORCID-Profile: Lorenzo Cangiano

Förderung

  • Velux Stiftung
  • PNRR Tuscany Health Ecosystem milestones 4.3.2 and 8.9.1

Zitieren

APA

Cangiano, L., & Asteriti, S. (2023). An Ex Vivo Electroretinographic Apparatus for the mL-Scale Testing of Drugs to One Day and Beyond. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411346

Vancouver

Cangiano L, Asteriti S. An Ex Vivo Electroretinographic Apparatus for the mL-Scale Testing of Drugs to One Day and Beyond. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411346

BibTeX
@article{Cangiano2023,
  author = {Cangiano, Lorenzo and Asteriti, Sabrina},
  title = {An Ex Vivo Electroretinographic Apparatus for the mL-Scale Testing of Drugs to One Day and Beyond},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411346}
}
Kostenlos starten →